The effect of the number of biopsy cores on the concordance between prostate biopsy and prostatectomy gleason score : A prostate volume-controlled study

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 6, 2008, Pages 989-992

  Antunes, Alberto A ^a   Leite, Katia Ramos ^a   Dall'Oglio, Marcos F ^a   Cury, Jose ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CASE CONTROL STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PREDICTION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; BIOPSY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 45549087027     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jemal A, Siege! R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Cooperberg MR, Broering JM, Litwin MS, et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004;171:1393-1401.
3. Bianco FJ Jr, Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta" ). Urology. 2005;66(5 Suppl):83-94.
4. Babaian RJ, Troncoso P, Bhadkamkar VA, Johnston DA. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer. 2001;91:1414-1422.
5. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate, J Urol. 1989; 142:71-74.
6. King CR. Patterns of prostate cancer biopsy grading: trends and clinical implications. Int J Cancer. 2000;90:305-311.
7. Lattouf JB, Saad F. Gleason score on biopsy: is it reliable for predicting the final grade on pathology? BJU Int. 2002;90:694-698.
8. Coogan CL, Latchamsetty KC, Greenfield], Corman JM, Lynch B, Porter CR. Increasing the number of biopsy cores improves the concordance of biopsy Gleason score to prostatectomy Gleason score. BJU Int. 2005;96:324-327.
9. Gore JL, Shariat SF, Miles BJ, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001;165:1554-1559.
10. San Francisco IF, DeWolf WC, Rosen S, Upton M, Olumi AF. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol. 2003;169:136-140.
11. Emiliozzi P, Maymone S, Paterno A, et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J Urol. 2004;172:2224-2226.
12. Mian BM, Lehr DJ, Moore CK, et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology. 2006;67:379-383.
13. Remzi M, Fong YK, Dobrovits M, et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005;1 74:1256-1260.
14. Bostwick DG, Foster CS. Examination in radical prostatectomy specimens: therapeutic and prognostic significance. In: Pathology of the Prostate. Philadelphia, Pa: WB Saunders; 1998:172. Major Problems in Pathology Series; vol 34.
15. Gleason DF. Histologic grading and staging of prostatic carcinoma. In: Tannenbaum M, ed. Urologic Pathology. Philadelphia, Pa: Lea & Feibeger; 1977; 171-187.
16. Epstein Jl, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29: 1228-1242.
17. King CR. Patterns of prostate cancer biopsy grading: trends and clinical implications, Int J Cancer. 2000;90:305-311.